DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,951,303 | $104,175,000 | 19.37% |
Vida Ventures Advisors, LLC | 2,960,046 | $62,280,000 | 15.62% |
Logos Global Management LP | 2,054,392 | $43,224,000 | 3.63% |
GREAT POINT PARTNERS LLC | 672,559 | $14,151,000 | 2.97% |
Octagon Capital Advisors LP | 583,649 | $12,280,000 | 2.54% |
COMMODORE CAPITAL LP | 305,125 | $6,420,000 | 2.24% |
RA Capital Management | 2,805,045 | $59,018,000 | 0.95% |
Altium Capital Management LP | 166,636 | $3,506,000 | 0.81% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 135,000 | $2,840,000 | 0.75% |
Soleus Capital Management, L.P. | 178,360 | $3,753,000 | 0.58% |
SPHERA FUNDS MANAGEMENT LTD. | 369,714 | $7,779,000 | 0.53% |
Vivo Capital, LLC | 577,642 | $12,154,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 787,000 | $16,558,000 | 0.29% |
Artal Group S.A. | 525,000 | $11,046,000 | 0.22% |
HHLR ADVISORS, LTD. | 1,000,000 | $21,040,000 | 0.22% |
EcoR1 Capital, LLC | 215,000 | $4,524,000 | 0.17% |
HARVARD MANAGEMENT CO INC | 107,252 | $2,257,000 | 0.13% |
Woodline Partners LP | 222,374 | $4,679,000 | 0.09% |
Redmond Asset Management, LLC | 12,513 | $263,000 | 0.08% |
Orbimed Advisors | 350,000 | $7,364,000 | 0.07% |
External links
This page lists DYNE THERAPEUTICS INC's shareholders in Q2 2021. To view DYNE THERAPEUTICS INC's shareholder history, click here.